NCT05550961
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
Clinical trial condition
Adenocarcinoma of Lung
Explore clinical trials studying Adenocarcinoma of Lung. Study availability and eligibility vary by location and protocol.
266 public trials
48 recruiting studies
Adenocarcinoma of Lung trial results
Recruiting
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
NCT06056115
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
- Locations
-
- The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital) Shijiazhuang, Hebei, China
NCT06031246
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +14 more
- Locations
-
- Chaoqiang Deng Shanghai, Please Select, China
NCT05838053
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
- Locations
-
- Shanghai Pulmonary Hospital Yangpu, Shanghai Municipality, China
NCT05733000
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT05537922
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Metropolitan Hospital Athens, Greece
- Shaare Zedek Medical Center Jerusalem, Israel
- Vall D'Hebron Institute of Oncology Barcelona, Spain
NCT05503667
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
Recruiting
Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
NCT03351842
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +11 more
- Locations
-
- Thoracic Surgery Department of Shanghai Pulmonary Hospital Shanghai, China
Enrolling by Invitation
Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
NCT06730477
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
- Union hospital, Tongji Medical college, Huazhong University of Science and Technology Wuhan, Hubei, China
Not Yet Recruiting
Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion
NCT07482605
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
- Locations
-
Not specified